The government’s Covid infection survey – regarded worldwide as the “gold standard” for surveillance of the virus – is being paused for several months
.
Contractors working on the project were told their work will soon come to an end. The ONS is understood to have told participants that the scheme is being paused after March. There will be some surveillance of positive tests in hospital patients and care homes, and vaccination rates are still being monitored, but the decision is a major reduction in the way the virus is tracked.
“We remain committed to monitoring the threat posed by Covid-19 through our range of surveillance systems and genomics capabilities, which report on infection rates, hospitalisations and the risks posed by new variants.”
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Associations between mortality from COVID-19 and other causes: A state-level analysisBackground During the COVID-19 pandemic, the high death toll from COVID-19 was accompanied by a rise in mortality from other causes of death. The objective of this study was to identify the relationship between mortality from COVID-19 and changes in mortality from specific causes of death by exploiting spatial variation in these relationships across US states. Methods We use cause-specific mortality data from CDC Wonder and population estimates from the US Census Bureau to examine relationships at the state level between mortality from COVID-19 and changes in mortality from other causes of death. We calculate age-standardized death rates (ASDR) for three age groups, nine underlying causes of death, and all 50 states and the District of Columbia between the first full year of the pandemic (March 2020-February 2021) and the year prior (March 2019-February 2020). We then estimate the relationship between changes in cause-specific ASDR and COVID-19 ASDR using linear regression analysis weighted by the size of the state’s population. Results We estimate that causes of death other than COVID-19 represent 19.6% of the total mortality burden associated with COVID-19 during the first year of the COVID-19 pandemic. At ages 25+, circulatory disease accounted for 51.3% of this burden while dementia (16.4%), other respiratory diseases (12.4%), influenza/pneumonia (8.7%) and diabetes (8.6%) also contribute. In contrast, there was an inverse association across states between COVID-19 death rates and changes in death rates from cancer. We found no state-level association between COVID-19 mortality and rising mortality from external causes. Conclusions States with unusually high death rates from COVID-19 experienced an even larger mortality burden than implied by those rates alone. Circulatory disease served as the most important route through which COVID-19 mortality affected death rates from other causes of death. Dementia and other respiratory diseases made the second and third l
Lire la suite »
Rupert Murdoch predicted ‘riots like never before’ if 2020 US election was overturned\n\t\t\tSubscribe to the FT for a global perspective on US politics, business and beyond.\n\t\t
Lire la suite »
Rudy Giuliani’s Potential Legal Jeopardy Over the 2020 ElectionRudy Giuliani’s potential legal jeopardy over the 2020 election
Lire la suite »
Early outpatient treatment of COVID-19 with metformin could reduce the risk of developing long COVIDIn a recent study posted to Preprints with The Lancet*, a team of researchers from the United States investigated whether early outpatient treatment of coronavirus disease 2019 (COVID-19) patients with fluvoxamine, ivermectin, or metformin could prevent long coronavirus disease (long COVID).
Lire la suite »
Should We be Concerned with Nicotine in Sport? Analysis from 60,802 Doping Control Tests in Italy - Sports MedicineBackground Nicotine is a psychostimulant drug with purported use in sports environments, though the use of nicotine among athletes has not been studied extensively. Objective The aim of this study was to assess the nicotine positivity rate in 60,802 anti-doping urine samples from 2012 to 2020. Methods Urine samples obtained in-competition at different national and international sports events held in Italy during the period 2012–2020 were analysed. All samples were from anonymous athletes that were collected and analysed at the WADA-accredited antidoping laboratory in Rome, Italy. Samples were analysed by gas chromatography coupled with mass spectrometry, with a cut-off concentration for nicotine of | 50 ng/mL. Results were stratified by year, sport and sex. Results An overall mean of 22.7% of the samples (n = 13,804; males: n = 11,099; females: n = 2705) showed nicotine intake, with male samples also displaying higher positivity rates than female (24.1% vs 18.5%). Sample positivity was higher during 2012–2014 (25–33%) than 2015–2020 (15–20%). Samples from team sports displayed a higher positivity rate than those from individual sports (31.4 vs 14.1%). Conclusions The current data demonstrates that one in five samples from a range of 90 sports test positive for nicotine in-competition. There is a lower positivity rate in endurance versus power/strength athletes and higher positivity rate in team versus individual sports, probably accounted for by differences in physiological and psychological demands and the desire for socialisation. WADA, international and national sports federations should consider these findings with concern, proactively investigate this phenomenon and act in order to protect the health and welfare of its athletes.
Lire la suite »
Duchess of Sussex dealt legal blow over Archetypes podcastMeghan Markle, Duchess of Sussex, denied right to trademark podcast Archetype. Meghan and Harry's Archewell Foundation launched in 2020
Lire la suite »